Vancouver, British Columbia (FSCwire) - EVITRADE Health Systems Corp.
(CSE:EVA, OTCQB: AXHLF) (the “Company” or “EVITRADE”) announces that the current negotiations on the non-binding LOI is to also
include Cantech’s genetics technology. This technology is applicable to a wide range of markets within the medical,
recreational cannabis and industrial hemp plant industries, including the emerging market of genetic mapping in both people and
domestic animals.
Cantech believes that with their years of field and laboratory work in the plant breeding industry, they are able
to apply this experience in a cross disciplinary manner for creating large genetic mapping databases using the latest in next
generation genetic sequencing platforms.
The mapping will be done at a molecular level and will have the opportunity to identify the organisms’ general
health, as well as any possible diseases that may arise from a genetic perspective (whether plant, animal or human).
The significance of this genetics technology is that it can be coupled along with advanced drug development
software; the data obtained from the genetic mapping can assist in determining the best CBD/THC combinations that an individual
would be most receptive and responsive to, based on their personal genetics. This will provide the ability to engineer
tailor made, patentable drug combinations for the medical cannabis and domestic animal industries and possibly for other
pharmacological applications.
Management looks forward to providing further details as to the consideration, final structure and other
technologies being negotiated into the definitive agreement as developments on the current CANTECH non-binding Letter of Intent
continue to be discussed.
Contact:
Ron Ozols, Director, EVITRADE Health Systems Corporation
(formerly Auxellence Health Corporation)
Email: ceo@auxellence.com or info@auxellence.com
Website: http://www.auxellence.com
CSE Micro-site: http://thecse.com/en/listings/technology/evitrade-health-systems-corp
About EVITRADE Health Systems Corporation (CSE: EVA, OTCQB: AXHLF)
EVITRADE (formerly Auxellence Health Corp.), was founded in 2013 to provide online health technologies and services
for resolving common health problems.
Disclaimers – Forward Looking Statements
This news release may contain forward-looking statements based on assumptions and judgments of management regarding
future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or
results to differ materially from those reflected in the forward looking statements. The company disclaims any intention or
obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its
business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings
with Canadian securities regulators which is posted on www.sedar.com, and http://thecse.com/en/listings/technology/evitrade-health-systems-corp.
This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities
described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX
Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE) accepts responsibility for the
adequacy or accuracy of this release.
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities
described herein in the United States. The securities described herein have not been registered under the United States
Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities law and may not be offered or sold in the
“United States”, as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the
U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.
To view this press release as a PDF file, click onto the following link:
public://news_release_pdf/evitrade12082017.pdf
Source: EVITRADE Health Systems Corp. (CSE:EVA, OTCQB:AXHLF)
To follow EVITRADE Health Systems Corp. on your favorite social media platform or financial websites, please click on the
icons below.
Maximum News Dissemination by FSCwire. http://www.fscwire.com
Copyright © 2017 FSCwire